 | | G2Y | | Name: | 1,6-dichloro-1,6-dideoxy-alpha-L-sorbofuranosyl 4-chloro-4-deoxy-beta-D-galactopyranoside | | Formula: | C12 H19 Cl3 O8 | | SMILES: | C2(C(C(O)C(OC1(OC(C(O)C1O)CCl)CCl)OC2CO)O)Cl | | InChi: | InChI=1S/C12H19Cl3O8/c13-1-4-7(17)10(20)12(3-14,22-4)23-11-9(19)8(18)6(15)5(2-16)21-11/h4-11,16-20H,1-3H2/t4-,5+,6-,7+,8-,9+,10-,11-,12-/m0/s1 | | Definition date: | 2018-05-03 | | Last modified: | 2020-04-16 | | Release date: | 2018-08-08 | | Identifier: | 1,6-dichloro-1,6-dideoxy-alpha-L-sorbofuranosyl 4-chloro-4-deoxy-beta-D-galactopyranoside |
|
 | | GNA | | Name: | 2,4-DEOXY-4-GUANIDINO-5-N-ACETYL-NEURAMINIC ACID | | Formula: | C12 H22 N4 O7 | | SMILES: | O=C(O)C1OC(C(O)C(O)CO)C(NC(=O)C)C(NC(=[N@H])N)C1 | | InChi: | InChI=1S/C12H22N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h5-10,17,19-20H,2-3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,7+,8+,9+,10+/m0/s1 | | Definition date: | 1999-07-08 | | Last modified: | 2020-04-13 | | Identifier: | 5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-erythro-L-manno-nononic acid |
|
 | | EDJ | | Name: | 2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-N-methylbenzene-1-carboximidic acid | | Formula: | C21 H21 Br N4 O5 | | SMILES: | c1(c(Br)cnc(n1)Nc2cc(OC)c(OC)c(OC)c2)Oc3ccccc3/C(O)=N/C | | InChi: | InChI=1S/C21H21BrN4O5/c1-23-19(27)13-7-5-6-8-15(13)31-20-14(22)11-24-21(26-20)25-12-9-16(28-2)18(30-4)17(10-12)29-3/h5-11H,1-4H3,(H,23,27)(H,24,25,26) | | Definition date: | 2018-01-02 | | Last modified: | 2020-04-13 | | Release date: | 2018-05-09 | | Identifier: | 2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-N-methylbenzene-1-carboximidic acid |
|
 | | NT2 | | Name: | 2,3,4,6-TETRA-O-SULFOHEXOPYRANOSE | | Formula: | C6 H12 O18 S4 | | SMILES: | O=S(=O)(O)OCC1OC(O)C(OS(=O)(=O)O)C(OS(=O)(=O)O)C1OS(=O)(=O)O | | InChi: | InChI=1S/C6H12O18S4/c7-6-5(24-28(17,18)19)4(23-27(14,15)16)3(22-26(11,12)13)2(21-6)1-20-25(8,9)10/h2-7H,1H2,(H,8,9,10)(H,11,12,13)(H,14,15,16)(H,17,18,19)/t2-,3-,4+,5-,6+/m1/s1 | | Definition date: | 2004-04-20 | | Last modified: | 2020-04-13 | | Identifier: | 2,3,4,6-tetra-O-sulfo-alpha-D-glucopyranose |
|
 | | 5KU | | Name: | (6R)-5-(acetylamino)-2,6-anhydro-3,4,5-trideoxy-4-[(diaminomethylidene)amino]-6-[(11R,12S)-12,13-dihydroxy-9-oxo-2,5,10-trioxa-8-azatridecan-11-yl]-D-threo-hex-2-enonic acid | | Formula: | C18 H31 N5 O10 | | SMILES: | COCCOCCNC(=O)OC(C1C(C(N=C(N)N)C=C(O1)C(O)=O)NC(=O)C)C(CO)O | | InChi: | InChI=1S/C18H31N5O10/c1-9(25)22-13-10(23-17(19)20)7-12(16(27)28)32-15(13)14(11(26)8-24)33-18(29)21-3-4-31-6-5-30-2/h7,10-11,13-15,24,26H,3-6,8H2,1-2H3,(H,21,29)(H,22,25)(H,27,28)(H4,19,20,23)/t10-,11+,13+,14-,15-/m1/s1 | | Definition date: | 2015-10-15 | | Last modified: | 2020-04-12 | | Release date: | 2016-03-02 | | Identifier: | (6R)-5-(acetylamino)-2,6-anhydro-3,4,5-trideoxy-4-[(diaminomethylidene)amino]-6-[(11R,12S)-12,13-dihydroxy-9-oxo-2,5,10-trioxa-8-azatridecan-11-yl]-D-threo-hex-2-enonic acid |
|
 | | SXG | | Name: | 2,3,4,5,6-pentafluoro-N-(2,3,5,6-tetrafluoro-4-sulfamoylphenyl)benzenesulfonamide | | Formula: | C12 H3 F9 N2 O4 S2 | | SMILES: | N[S](=O)(=O)c1c(F)c(F)c(N[S](=O)(=O)c2c(F)c(F)c(F)c(F)c2F)c(F)c1F | | InChi: | InChI=1S/C12H3F9N2O4S2/c13-1-2(14)6(18)12(7(19)3(1)15)29(26,27)23-10-4(16)8(20)11(28(22,24)25)9(21)5(10)17/h23H,(H2,22,24,25) | | Definition date: | 2019-07-26 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 2,3,5,6-tetrakis(fluoranyl)-4-[[2,3,4,5,6-pentakis(fluoranyl)phenyl]sulfonylamino]benzenesulfonamide |
|
 | | QKP | | Name: | 2-{4-[(2R)-2-hydroxy-3-(4-methylpiperazin-1-yl)propoxy]-3,5-dimethylphenyl}-5,7-dimethoxy-4H-1-benzopyran-4-one | | Formula: | C27 H34 N2 O6 | | SMILES: | c2(OCC(CN1CCN(CC1)C)O)c(cc(cc2C)C3=CC(c4c(cc(cc4O3)OC)OC)=O)C | | InChi: | InChI=1S/C27H34N2O6/c1-17-10-19(23-14-22(31)26-24(33-5)12-21(32-4)13-25(26)35-23)11-18(2)27(17)34-16-20(30)15-29-8-6-28(3)7-9-29/h10-14,20,30H,6-9,15-16H2,1-5H3/t20-/m1/s1 | | Definition date: | 2019-11-08 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 2-{4-[(2R)-2-hydroxy-3-(4-methylpiperazin-1-yl)propoxy]-3,5-dimethylphenyl}-5,7-dimethoxy-4H-1-benzopyran-4-one |
|
 | | S6V | | Name: | 1-[2-(2-oxidanylidenepyrrolidin-1-yl)ethyl]-3-phenyl-urea | | Formula: | C13 H17 N3 O2 | | SMILES: | O=C(NCCN1CCCC1=O)Nc2ccccc2 | | InChi: | InChI=1S/C13H17N3O2/c17-12-7-4-9-16(12)10-8-14-13(18)15-11-5-2-1-3-6-11/h1-3,5-6H,4,7-10H2,(H2,14,15,18) | | Definition date: | 2020-03-04 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 1-[2-(2-oxidanylidenepyrrolidin-1-yl)ethyl]-3-phenyl-urea |
|
 | | Q8D | | Name: | 1-cyclohexyl-1H-benzotriazole-5-carboxylic acid | | Formula: | C13 H15 N3 O2 | | SMILES: | c12cc(C(O)=O)ccc1n(nn2)C3CCCCC3 | | InChi: | InChI=1S/C13H15N3O2/c17-13(18)9-6-7-12-11(8-9)14-15-16(12)10-4-2-1-3-5-10/h6-8,10H,1-5H2,(H,17,18) | | Definition date: | 2019-10-02 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 1-cyclohexyl-1H-benzotriazole-5-carboxylic acid |
|
 | | Q8G | | Name: | 1-cyclohexyl-1H-benzimidazole-5-carboxylic acid | | Formula: | C14 H16 N2 O2 | | SMILES: | c12ncn(c1ccc(C(O)=O)c2)C3CCCCC3 | | InChi: | InChI=1S/C14H16N2O2/c17-14(18)10-6-7-13-12(8-10)15-9-16(13)11-4-2-1-3-5-11/h6-9,11H,1-5H2,(H,17,18) | | Definition date: | 2019-10-02 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 1-cyclohexyl-1H-benzimidazole-5-carboxylic acid |
|
 | | Q8M | | Name: | 5-bromo-3-chloro-N-(1-cyclopentyl-1H-imidazol-4-yl)-2-hydroxybenzene-1-sulfonamide | | Formula: | C14 H15 Br Cl N3 O3 S | | SMILES: | C1CC(CC1)n3cc(NS(c2cc(cc(c2O)Cl)Br)(=O)=O)nc3 | | InChi: | InChI=1S/C14H15BrClN3O3S/c15-9-5-11(16)14(20)12(6-9)23(21,22)18-13-7-19(8-17-13)10-3-1-2-4-10/h5-8,10,18,20H,1-4H2 | | Definition date: | 2019-10-03 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 5-bromo-3-chloro-N-(1-cyclopentyl-1H-imidazol-4-yl)-2-hydroxybenzene-1-sulfonamide |
|
 | | Q8P | | Name: | 4-{[(5-bromo-3-chloro-2-hydroxyphenyl)sulfonyl]amino}-1-cyclopentyl-N-methyl-1H-imidazole-2-carboxamide | | Formula: | C16 H18 Br Cl N4 O4 S | | SMILES: | C1CC(CC1)n3cc(NS(c2cc(cc(c2O)Cl)Br)(=O)=O)nc3C(NC)=O | | InChi: | InChI=1S/C16H18BrClN4O4S/c1-19-16(24)15-20-13(8-22(15)10-4-2-3-5-10)21-27(25,26)12-7-9(17)6-11(18)14(12)23/h6-8,10,21,23H,2-5H2,1H3,(H,19,24) | | Definition date: | 2019-10-03 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 4-{[(5-bromo-3-chloro-2-hydroxyphenyl)sulfonyl]amino}-1-cyclopentyl-N-methyl-1H-imidazole-2-carboxamide |
|
 | | Q8S | | Name: | 5-bromo-3-chloro-N-(1-cyclopentyl-2-methyl-1H-imidazol-4-yl)-2-hydroxybenzene-1-sulfonamide | | Formula: | C15 H17 Br Cl N3 O3 S | | SMILES: | C1CC(CC1)n3cc(NS(c2cc(cc(c2O)Cl)Br)(=O)=O)nc3C | | InChi: | InChI=1S/C15H17BrClN3O3S/c1-9-18-14(8-20(9)11-4-2-3-5-11)19-24(22,23)13-7-10(16)6-12(17)15(13)21/h6-8,11,19,21H,2-5H2,1H3 | | Definition date: | 2019-10-03 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 5-bromo-3-chloro-N-(1-cyclopentyl-2-methyl-1H-imidazol-4-yl)-2-hydroxybenzene-1-sulfonamide |
|
 | | QBM | | Name: | 6-methyl-3-(propylsulfanyl)-1,2,4-triazin-5-ol | | Formula: | C7 H11 N3 O S | | SMILES: | CCCSc1nnc(c(O)n1)C | | InChi: | InChI=1S/C7H11N3OS/c1-3-4-12-7-8-6(11)5(2)9-10-7/h3-4H2,1-2H3,(H,8,10,11) | | Definition date: | 2019-10-10 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 6-methyl-3-(propylsulfanyl)-1,2,4-triazin-5-ol |
|
 | | QBP | | Name: | 5-[4-(trifluoromethyl)phenyl]-1H-tetrazole | | Formula: | C8 H5 F3 N4 | | SMILES: | C(F)(F)(c2ccc(c1nnnn1)cc2)F | | InChi: | InChI=1S/C8H5F3N4/c9-8(10,11)6-3-1-5(2-4-6)7-12-14-15-13-7/h1-4H,(H,12,13,14,15) | | Definition date: | 2019-10-10 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 5-[4-(trifluoromethyl)phenyl]-1H-tetrazole |
|
 | | AYR | | Name: | (2E,4E)-5-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one | | Formula: | C17 H19 N O3 | | SMILES: | C(c2ccc1OCOc1c2)=[C@H]C=[C@H]C(N3CCCCC3)=O | | InChi: | InChI=1S/C17H19NO3/c19-17(18-10-4-1-5-11-18)7-3-2-6-14-8-9-15-16(12-14)21-13-20-15/h2-3,6-9,12H,1,4-5,10-11,13H2/b6-2+,7-3+ | | Definition date: | 2018-12-13 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | (2E,4E)-5-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one |
|
 | | U0M | | Name: | 5-fluoro-1-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]-1,2,3,6-tetrahydropyridine | | Formula: | C9 H12 F N3 S | | SMILES: | C=1CCN(CC=1F)Cc2nnc(C)s2 | | InChi: | InChI=1S/C9H12FN3S/c1-7-11-12-9(14-7)6-13-4-2-3-8(10)5-13/h3H,2,4-6H2,1H3 | | Definition date: | 2020-04-08 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 5-fluoro-1-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]-1,2,3,6-tetrahydropyridine |
|
 | | U0P | | Name: | N'-cyclopropyl-N-methyl-N-[(5-methyl-1,2-oxazol-3-yl)methyl]urea | | Formula: | C10 H15 N3 O2 | | SMILES: | C(N(C)Cc1noc(c1)C)(NC2CC2)=O | | InChi: | InChI=1S/C10H15N3O2/c1-7-5-9(12-15-7)6-13(2)10(14)11-8-3-4-8/h5,8H,3-4,6H2,1-2H3,(H,11,14) | | Definition date: | 2020-04-08 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | N'-cyclopropyl-N-methyl-N-[(5-methyl-1,2-oxazol-3-yl)methyl]urea |
|
 | | U0S | | Name: | (5S)-7-(pyrazin-2-yl)-2-oxa-7-azaspiro[4.4]nonane | | Formula: | C11 H15 N3 O | | SMILES: | C3CC2(CN(c1nccnc1)CC2)CO3 | | InChi: | InChI=1S/C11H15N3O/c1-5-14(10-7-12-3-4-13-10)8-11(1)2-6-15-9-11/h3-4,7H,1-2,5-6,8-9H2/t11-/m0/s1 | | Definition date: | 2020-04-08 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | (5S)-7-(pyrazin-2-yl)-2-oxa-7-azaspiro[4.4]nonane |
|
 | | U0V | | Name: | 2-fluoro-N-[2-(pyridin-4-yl)ethyl]benzamide | | Formula: | C14 H13 F N2 O | | SMILES: | c2(CCNC(c1c(F)cccc1)=O)ccncc2 | | InChi: | InChI=1S/C14H13FN2O/c15-13-4-2-1-3-12(13)14(18)17-10-7-11-5-8-16-9-6-11/h1-6,8-9H,7,10H2,(H,17,18) | | Definition date: | 2020-04-08 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 2-fluoro-N-[2-(pyridin-4-yl)ethyl]benzamide |
|
 | | QF1 | | Name: | 5-bromo-3-chloro-N-[1-cyclopentyl-2-(methylsulfonyl)-1H-imidazol-4-yl]-2-hydroxybenzene-1-sulfonamide | | Formula: | C15 H17 Br Cl N3 O5 S2 | | SMILES: | CS(c2nc(cn2C1CCCC1)NS(c3cc(cc(c3O)Cl)Br)(=O)=O)(=O)=O | | InChi: | InChI=1S/C15H17BrClN3O5S2/c1-26(22,23)15-18-13(8-20(15)10-4-2-3-5-10)19-27(24,25)12-7-9(16)6-11(17)14(12)21/h6-8,10,19,21H,2-5H2,1H3 | | Definition date: | 2019-10-21 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 5-bromo-3-chloro-N-[1-cyclopentyl-2-(methylsulfonyl)-1H-imidazol-4-yl]-2-hydroxybenzene-1-sulfonamide |
|
 | | U1V | | Name: | 1-(4-fluoro-2-methylphenyl)methanesulfonamide | | Formula: | C8 H10 F N O2 S | | SMILES: | c1cc(CS(N)(=O)=O)c(C)cc1F | | InChi: | InChI=1S/C8H10FNO2S/c1-6-4-8(9)3-2-7(6)5-13(10,11)12/h2-4H,5H2,1H3,(H2,10,11,12) | | Definition date: | 2020-04-08 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 1-(4-fluoro-2-methylphenyl)methanesulfonamide |
|
 | | T9J | | Name: | Nalpha-acetyl-N-(3-bromoprop-2-yn-1-yl)-L-tyrosinamide | | Formula: | C14 H15 Br N2 O3 | | SMILES: | N(C(Cc1ccc(cc1)O)C(=O)NCC#CBr)C(C)=O | | InChi: | InChI=1S/C14H15BrN2O3/c1-10(18)17-13(14(20)16-8-2-7-15)9-11-3-5-12(19)6-4-11/h3-6,13,19H,8-9H2,1H3,(H,16,20)(H,17,18)/t13-/m0/s1 | | Definition date: | 2020-03-18 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | Nalpha-acetyl-N-(3-bromoprop-2-yn-1-yl)-L-tyrosinamide |
|
 | | Q1Y | | Name: | 5-[(3S,4R)-3-{[(2H-1,3-benzodioxol-5-yl)oxy]methyl}piperidin-4-yl]-2-fluoro-N-[(2H-indazol-3-yl)methyl]benzamide | | Formula: | C28 H27 F N4 O4 | | SMILES: | c6(OCC1C(CCNC1)c2ccc(c(c2)C(NCc4c3c(cccc3)nn4)=O)F)cc5c(OCO5)cc6 | | InChi: | InChI=1S/C28H27FN4O4/c29-23-7-5-17(11-22(23)28(34)31-14-25-21-3-1-2-4-24(21)32-33-25)20-9-10-30-13-18(20)15-35-19-6-8-26-27(12-19)37-16-36-26/h1-8,11-12,18,20,30H,9-10,13-16H2,(H,31,34)(H,32,33)/t18-,20-/m0/s1 | | Definition date: | 2019-09-06 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 5-[(3S,4R)-3-{[(2H-1,3-benzodioxol-5-yl)oxy]methyl}piperidin-4-yl]-2-fluoro-N-[(2H-indazol-3-yl)methyl]benzamide |
|
 | | C6O | | Name: | 6-(2-chloranyl-3-fluoranyl-phenyl)-5-methyl-2-[[3-methyl-4-(4-methylpiperazin-1-yl)phenyl]amino]-8-[(3S)-1-propanoylpiperidin-3-yl]pyrido[2,3-d]pyrimidin-7-one | | Formula: | C34 H39 Cl F N7 O2 | | SMILES: | CCC(=O)N1CCC[CH](C1)N2C(=O)C(=C(C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc23)c6cccc(F)c6Cl | | InChi: | InChI=1S/C34H39ClFN7O2/c1-5-29(44)42-13-7-8-24(20-42)43-32-26(22(3)30(33(43)45)25-9-6-10-27(36)31(25)35)19-37-34(39-32)38-23-11-12-28(21(2)18-23)41-16-14-40(4)15-17-41/h6,9-12,18-19,24H,5,7-8,13-17,20H2,1-4H3,(H,37,38,39)/t24-/m0/s1 | | Definition date: | 2019-04-11 | | Last modified: | 2020-04-10 | | Release date: | 2020-04-15 | | Identifier: | 6-(2-chloranyl-3-fluoranyl-phenyl)-5-methyl-2-[[3-methyl-4-(4-methylpiperazin-1-yl)phenyl]amino]-8-[(3~{S})-1-propanoylpiperidin-3-yl]pyrido[2,3-d]pyrimidin-7-one |
|